Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study)
暂无分享,去创建一个
R. Avery | D. Pieramici | M. Rabena | A. Castellarin | M. Nasir | N. Steinle | D. Dhoot | R. See | M. Bennett | S. Couvillion